Core Insights - Aclarion, Inc. has established a commercial agreement with Scripps Health to expand access to its Nociscan technology for chronic low back pain diagnosis in the San Diego area [1][2][3] - Nociscan utilizes MR Spectroscopy and AI to help physicians identify the sources of chronic low back pain, distinguishing between painful and nonpainful discs [3][5] - The agreement will benefit over 3.2 million people in the greater San Diego Metro area, enhancing the capabilities of leading spine physicians at Scripps Health [1][2] Company Overview - Aclarion is a healthcare technology company focused on chronic low back pain, leveraging biomarkers and proprietary AI algorithms [1][5] - Nociscan is the first evidence-supported SaaS platform designed to noninvasively assist physicians in diagnosing disc-related pain [3][5] - The technology processes MRS data from MRI machines to quantify chemical biomarkers associated with disc pain, providing critical insights for treatment optimization [5][6] Industry Context - Chronic low back pain is a significant global healthcare issue, affecting approximately 266 million people worldwide [3] - The partnership with Scripps Health is expected to enhance diagnostic capabilities and treatment strategies for patients suffering from chronic low back pain [2][3]
Aclarion Announces First Commercial Agreement with Scripps Health